Bioteque Statistics

Total Valuation

Bioteque has a market cap or net worth of TWD 8.90 billion. The enterprise value is 7.98 billion.

Market Cap	8.90B
Enterprise Value	7.98B

Important Dates

The next estimated earnings date is Wednesday, September 11, 2024.

Earnings Date	Sep 11, 2024
Ex-Dividend Date	Jul 30, 2024

Share Statistics

Bioteque has 69.30 million shares outstanding. The number of shares has decreased by -0.01% in one year.

Shares Outstanding	69.30M
Shares Change (YoY)	-0.01%
Shares Change (QoQ)	-0.18%
Owned by Insiders (%)	2.97%
Owned by Institutions (%)	19.86%
Float	55.87M

Valuation Ratios

The trailing PE ratio is 17.85 and the forward PE ratio is 23.32.

PE Ratio	17.85
Forward PE	23.32
PS Ratio	4.38
PB Ratio	2.82
P/FCF Ratio	12.65
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 10.25, with an EV/FCF ratio of 11.33.

EV / Earnings	15.90
EV / Sales	3.93
EV / EBITDA	10.25
EV / EBIT	12.84
EV / FCF	11.33

Financial Position

The company has a current ratio of 2.43, with a Debt / Equity ratio of 26.33.

Current Ratio	2.43
Quick Ratio	2.09
Debt / Equity	26.33
Debt / EBITDA	1.07
Debt / FCF	1.18
Interest Coverage	56.89

Financial Efficiency

Return on equity (ROE) is 16.48% and return on invested capital (ROIC) is 9.96%.

Return on Equity (ROE)	16.48%
Return on Assets (ROA)	8.24%
Return on Capital (ROIC)	9.96%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.43
Inventory Turnover	3.92

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +18.98% in the last 52 weeks. The beta is 0.50, so Bioteque's price volatility has been lower than the market average.

Beta (5Y)	0.50
52-Week Price Change	+18.98%
50-Day Moving Average	133.97
200-Day Moving Average	123.34
Relative Strength Index (RSI)	33.96
Average Volume (20 Days)	188,115

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Bioteque had revenue of TWD 2.03 billion and earned 501.47 million in profits. Earnings per share was 7.20.

Revenue	2.03B
Gross Profit	875.66M
Operating Income	621.00M
Pretax Income	628.09M
Net Income	501.47M
EBITDA	763.47M
EBIT	621.00M
Earnings Per Share (EPS)	7.20

Full Income Statement

Balance Sheet

The company has 1.76 billion in cash and 830.89 million in debt, giving a net cash position of 928.98 million or 13.41 per share.

Cash & Cash Equivalents	1.76B
Total Debt	830.89M
Net Cash	928.98M
Net Cash Per Share	13.41
Equity (Book Value)	3.16B
Book Value Per Share	45.53
Working Capital	1.39B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 799.76 million and capital expenditures -95.94 million, giving a free cash flow of 703.82 million.

Operating Cash Flow	799.76M
Capital Expenditures	-95.94M
Free Cash Flow	703.82M
FCF Per Share	10.16

Full Cash Flow Statement

Margins

Gross margin is 43.10%, with operating and profit margins of 30.57% and 24.68%.

Gross Margin	43.10%
Operating Margin	30.57%
Pretax Margin	30.92%
Profit Margin	24.68%
EBITDA Margin	37.58%
EBIT Margin	30.57%
FCF Margin	34.64%

Dividends & Yields

This stock pays an annual dividend of 4.50, which amounts to a dividend yield of 3.46%.

Dividend Per Share	4.50
Dividend Yield	3.46%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	62.19%
Buyback Yield	0.01%
Shareholder Yield	3.47%
Earnings Yield	5.60%
FCF Yield	7.90%

Dividend Details

Stock Splits

The last stock split was on August 20, 2015. It was a reverse split with a ratio of 0.8006917977.

Last Split Date	Aug 20, 2015
Split Type	Reverse
Split Ratio	0.8006917977